Literature DB >> 14575721

Adeno-associated viral vectors for retinal gene transfer.

Enrico M Surace1, Alberto Auricchio.   

Abstract

Vectors derived from adeno-associated viruses (AAV) represent a promising tool for retinal gene transfer in pre-clinical and clinical settings. AAV vectors efficiently transduce dividing and non-dividing cells, escape cellular immunity and result in long-non-term transduction. In addition, they may be targeted to specific retinal cell types by taking advantage of surface proteins from various AAV serotypes thus limiting transfer of therapeutic genes to those cells requiring correction. This review will provide an overview of the properties of AAV vectors followed by a detailed report of their use in retinal gene transfer for mendelian and non-mendelian disorders.

Entities:  

Mesh:

Year:  2003        PMID: 14575721     DOI: 10.1016/s1350-9462(03)00052-1

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  12 in total

Review 1.  Adeno-associated virus vectors: potential applications for cancer gene therapy.

Authors:  Chengwen Li; Dawn E Bowles; Terry van Dyke; Richard Jude Samulski
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

2.  High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.

Authors:  Hilda Petrs-Silva; Astra Dinculescu; Qiuhong Li; Seok-Hong Min; Vince Chiodo; Ji-Jing Pang; Li Zhong; Sergei Zolotukhin; Arun Srivastava; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2008-12-16       Impact factor: 11.454

3.  Nanomaterials in controlled drug release.

Authors:  Xin-Jun Cai; Ying-Ying Xu
Journal:  Cytotechnology       Date:  2011-07-01       Impact factor: 2.058

4.  Changes in adeno-associated virus-mediated gene delivery in retinal degeneration.

Authors:  Kathleen D Kolstad; Deniz Dalkara; Karen Guerin; Meike Visel; Natalie Hoffmann; David V Schaffer; John G Flannery
Journal:  Hum Gene Ther       Date:  2010-05       Impact factor: 5.695

5.  AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa.

Authors:  Deniz Dalkara; Kathleen D Kolstad; Karen I Guerin; Natalie V Hoffmann; Meike Visel; Ryan R Klimczak; David V Schaffer; John G Flannery
Journal:  Mol Ther       Date:  2011-04-26       Impact factor: 11.454

6.  Comparison of the transduction efficiency of tyrosine-mutant adeno-associated virus serotype vectors in kidney.

Authors:  Yan F Qi; Qiu H Li; Vinayak Shenoy; Michael Zingler; Joo Y Jun; Amrisha Verma; Michael J Katovich; Mohan K Raizada
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-01       Impact factor: 2.557

Review 7.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

8.  AAV-mediated local delivery of interferon-beta for the treatment of retinoblastoma in preclinical models.

Authors:  Chie-Schin Shih; Nikia Laurie; Jeremy Holzmacher; Yunyu Spence; Amit C Nathwani; Andrew M Davidoff; Michael A Dyer
Journal:  Neuromolecular Med       Date:  2009-03-22       Impact factor: 3.843

9.  rAAV-mediated subcellular targeting of optogenetic tools in retinal ganglion cells in vivo.

Authors:  Chaowen Wu; Elena Ivanova; Yi Zhang; Zhuo-Hua Pan
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

10.  Evaluation of the adeno-associated virus mediated long-term expression of channelrhodopsin-2 in the mouse retina.

Authors:  Elena Ivanova; Zhuo-Hua Pan
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.